JPS645904B2 - - Google Patents

Info

Publication number
JPS645904B2
JPS645904B2 JP54086409A JP8640979A JPS645904B2 JP S645904 B2 JPS645904 B2 JP S645904B2 JP 54086409 A JP54086409 A JP 54086409A JP 8640979 A JP8640979 A JP 8640979A JP S645904 B2 JPS645904 B2 JP S645904B2
Authority
JP
Japan
Prior art keywords
sheet
prosthetic material
porous polytetrafluoroethylene
cardiac
medical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP54086409A
Other languages
Japanese (ja)
Other versions
JPS5611062A (en
Inventor
Yasuharu Imai
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to JP8640979A priority Critical patent/JPS5611062A/en
Publication of JPS5611062A publication Critical patent/JPS5611062A/en
Publication of JPS645904B2 publication Critical patent/JPS645904B2/ja
Granted legal-status Critical Current

Links

Landscapes

  • Materials For Medical Uses (AREA)

Description

【発明の詳細な説明】 本発明は医療用シート状補綴材料、特に心蔵血
管系に用いる医療用シート状補綴材料に関するも
のである。
DETAILED DESCRIPTION OF THE INVENTION The present invention relates to a medical sheet-like prosthetic material, particularly to a medical sheet-like prosthetic material for use in the cardiac vasculature.

病変あるいは損傷した血管、心蔵組織等を外科
手術により人工の材料を用いて補修、修復する研
究は、1950年代に始まり、特に最近の20年間にプ
ラスチツク材料の進歩と並行して大きく進歩し
た。
Research into surgically repairing and restoring diseased or damaged blood vessels, cardiac tissues, etc. using artificial materials began in the 1950s, and has made great progress, particularly in the last 20 years, in parallel with advances in plastic materials.

その中で、寸法、形成、取扱性、保存性などの
諸点において最も実用的と考えられる材料は、ポ
リエステル(商品名:ダクロンなど)およびポリ
テトラフロロエチレン(商品名:テフロン)の糸
を製織あるいは編織してつくつた布状あるいは管
状の医療用補綴材料である。これらの補綴材料は
現在種々の形状、構造、寸法で様々の心臓血管外
科手術に多用されているが、次の様な欠点があ
る。
Among these, the most practical materials in terms of dimensions, formation, ease of handling, storage stability, etc. are woven or made from threads of polyester (product name: Dacron, etc.) and polytetrafluoroethylene (product name: Teflon). It is a cloth-like or tubular medical prosthetic material made by knitting and weaving. Although these prosthetic materials are currently widely used in a variety of cardiovascular surgical procedures in a variety of shapes, structures, and sizes, they suffer from the following drawbacks.

人工心肺を使用する体外循環下の心臓大血管の
手術では、ヘバリン使用以外にも、血小板その他
の凝固因子の欠乏により血液凝固機転が正常でな
く、出血、凝固時間が著明に延長する。したがつ
て体外循環終了後の止血は重要な問題である。従
来の補綴材料は製織または編織した布または管で
あるため、その織目あるいは編目を通つて漏出す
る血液が多量であり、このため織目あるいは編目
を人為的に凝血によつて封じる操作であるプレク
ロツテイングを必要とする。またこのような前処
置をしても、長時間体外循環後には出血がみられ
ることもあり、止血操作に長時間を要する。また
従来の補綴材料は内面が粗面であるから、強い血
流があたると溶血の原因となり、また抗血栓性が
低いため、内面に血栓形成がみられ、塞栓症の原
因となることがある。
In cardiac and large vessel surgery under extracorporeal circulation using a heart-lung machine, in addition to the use of heparin, the blood coagulation mechanism is not normal due to a deficiency of platelets and other coagulation factors, resulting in significantly prolonged bleeding and coagulation time. Therefore, hemostasis after completion of extracorporeal circulation is an important issue. Since conventional prosthetic materials are woven or knitted cloth or tubes, a large amount of blood leaks through the weaves or stitches, and therefore the weave or stitches are artificially sealed with blood clots. Requires pre-cropping. Furthermore, even with such pretreatment, bleeding may occur after prolonged extracorporeal circulation, and it takes a long time to stop the bleeding. Furthermore, because conventional prosthetic materials have a rough inner surface, strong blood flow can cause hemolysis, and their low antithrombotic properties can lead to thrombus formation on the inner surface, which can lead to embolism. .

また最近、製織あるいは編織に依らず、成形品
を特定条件下で延伸して得られる延伸多孔質ポリ
テトラフロロエチレン(以下、ポリテトラフロロ
エチレンをPTFEと略記する)からつくつたチユ
ーブが人工血管として注目を集めている。この材
料の人工血管として最初の応用研究は、松本等に
より昭和46年10月に札幌で開かれた第9回日本人
工臓器学会において発表され“Porous
Polytetrafluoroethyleneの人工血管への応用”
として1972年3月15日発行、「人工臓器」第1巻
第1号に掲載されている。また外国においては、
Soyer等のSurgery第72巻(1972)、第864頁“A
New Venous Prostheses”が最初の英文によ
る研究報告である。これらの研究以後、現在迄に
数多くの研究報告が行なわれているが、これらを
要約すれば延伸多孔質PTFEからつくつた管が今
迄の人工血管材料の中でも適用範囲が広く、手術
後の開存率も高いということであろう。
Recently, tubes made from expanded porous polytetrafluoroethylene (hereinafter abbreviated as PTFE), which is obtained by stretching a molded product under specific conditions, have been developed as artificial blood vessels, without relying on weaving or knitting. It is attracting attention. The first applied research on this material as an artificial blood vessel was presented by Matsumoto et al. at the 9th Japanese Society for Artificial Organs held in Sapporo in October 1971, and was titled “Porous.
Application of Polytetrafluoroethylene to Artificial Blood Vessels”
Published on March 15, 1972, in "Artificial Organs" Volume 1, No. 1. Also, in foreign countries,
Soyer et al., Surgery Vol. 72 (1972), p. 864 “A.
"New Venous Prostheses" was the first research report written in English. Since these studies, numerous research reports have been published up to now, but to summarize them, tubes made from expanded porous PTFE have This means that it has a wide range of applications among artificial blood vessel materials, and has a high patency rate after surgery.

また、延伸多孔質PTFE材料の人工血管および
補綴材料に関する発明および考案も数件知られて
いる。それらを年代順に列記すれば、特公昭52−
9074号(特開昭49−22792号)、実公昭52−39838
号(実開昭49−82593号)、実公昭52−39839号
(実開昭49−82594号)、特公昭53−8362号(特開
昭50−102673号)、特公昭53−39719号(特開昭50
−135894号)、特開昭51−5897号、特開昭51−
48597号、特開昭53−90698号などである。これら
の中で二層構造の補綴材料に関するものは、特公
昭52−9074号、特開昭51−5897号、特開昭51−
48597号および特開昭53−90698号である。
Additionally, several inventions and ideas regarding artificial blood vessels and prosthetic materials made of expanded porous PTFE materials are known. Listing them in chronological order, the
No. 9074 (Unexamined Japanese Patent Publication No. 49-22792), Publication No. 52-39838
(Utility Model Publication No. 49-82593), Utility Model Publication No. 52-39839 (Utility Model Application No. 49-82594), Special Publication No. 53-8362 (Japanese Utility Model Publication No. 50-102673), Japanese Patent Publication No. 53-39719 ( Tokukai 1975
-135894), JP-A-51-5897, JP-A-51-
No. 48597, JP-A No. 53-90698, etc. Among these, those related to two-layer prosthetic materials are disclosed in Japanese Patent Publication No. 52-9074, Japanese Patent Application Publication No. 5897-1973, and Japanese Patent Application Publication No. 51-51-
No. 48597 and Japanese Patent Application Laid-Open No. 53-90698.

先ず、特公昭52−9074号は、延伸多孔質PTFE
チユーブの外周に同じく延伸多孔質PTFEのテー
プを螺旋状に巻付けて延伸多孔質PTFEチユーブ
単独のものよりも耐圧性および縫合糸の保持性を
向上させた人工血管である。この構造の人工血管
は現在既に米国、欧州などにおいて広く使用さ
れ、既に述べたように多くの医学論文によつて高
い開存率、良好な保存性、取扱性などの好結果が
報告されている。
First of all, Special Publication No. 52-9074 was developed for expanded porous PTFE.
This artificial blood vessel has expanded porous PTFE tape wrapped around the outer circumference of the tube in a helical manner to improve pressure resistance and suture retention than an expanded porous PTFE tube alone. Artificial blood vessels with this structure are already widely used in the United States, Europe, and other countries, and as already mentioned, many medical papers have reported good results such as high patency rate, good preservation, and ease of handling. .

次に、特開昭51−5897号は、従来の製織あるい
は編織人工血管の外周面に延伸多孔質PTFEを被
着させた人工血管であつて、その目的は製織あり
いは編織人工血管を用いる手術時に必要なプレク
ロテイングを省略できるようにしたものである。
従つて、この人工血管ではこの目的は達成される
けれども、血管内面の抗NFH性、抗血栓性は従
来の人工血管と変らず、また血管外面への体組織
への反応性は、PTFE固有の滑性のため劣る傾向
がある。
Next, JP-A-51-5897 discloses an artificial blood vessel in which expanded porous PTFE is coated on the outer peripheral surface of a conventional woven or knitted artificial blood vessel, and the purpose is to use the woven or knitted artificial blood vessel. This allows the pre-clotting required during surgery to be omitted.
Therefore, although this purpose is achieved with this artificial blood vessel, the anti-NFH and antithrombotic properties of the inner surface of the blood vessel are the same as those of conventional artificial blood vessels, and the reactivity of the outer surface of the blood vessel to body tissue is unique to PTFE. It tends to be inferior due to its slipperiness.

次に、特開昭53−90698号に開示された人工血
管は、延伸多孔質PTFEチユーブの外周面に生体
組織反応性の高いポリウレタンのような樹脂の連
続多孔質被覆層を設けた2層構造ものであつて、
その目的は生体組織反応性の高い樹脂によつて人
工血管の生体との結合性を高め、また血液透析患
者のシヤントとして使用した際の注射針による穿
刺穴を閉じる効果を付与することにある。
Next, the artificial blood vessel disclosed in JP-A No. 53-90698 has a two-layer structure in which a continuous porous coating layer of a resin such as polyurethane, which is highly reactive to living tissues, is provided on the outer peripheral surface of a stretched porous PTFE tube. It is a thing,
The purpose is to improve the bond between the artificial blood vessel and the living body by using a resin that is highly reactive to living tissue, and to provide the effect of closing the puncture hole made by an injection needle when used as a shunt for hemodialysis patients.

なお、特開昭51−48597号は特公昭52−9074号
の人工血管と実質的に同じと考えられるものであ
る。
Note that JP-A No. 51-48597 is considered to be substantially the same as the artificial blood vessel disclosed in JP-A No. 52-9074.

上述したように、延伸多孔質PTFEは単独ある
いは他の材料と組合せて医療用補綴材料として既
に使用されてはいるが、今迄使われているものは
殆んど全て管状で比較的細い血管の補綴に用いら
れており、太い血管(内径10mm以上)および心臓
パツチ等のシート状または布状補綴材料として
は、延伸多孔質PTFEシートを4層積層した膜を
種々の心臓手術に適用したことが「胸部外科」第
31巻、第1号(昭和53年1月)別冊に「新い
Expanded Polytetrafluoroethyleneの臨床応用」
として坂本、今井により発表されているにすぎな
い。
As mentioned above, expanded porous PTFE has already been used as a medical prosthetic material either alone or in combination with other materials, but almost all of the materials used to date have been tubular and relatively small blood vessels. It is used in prosthetics, and as a sheet or cloth prosthetic material for large blood vessels (inner diameter 10 mm or more) and heart patches, a membrane made of four layers of expanded porous PTFE sheets has been applied to various heart surgeries. "Thoracic Surgery" No.
Volume 31, No. 1 (January 1978), a separate issue entitled “New
"Clinical Application of Expanded Polytetrafluoroethylene"
It has only been announced by Sakamoto and Imai as follows.

ところで、心臓外科手術用のシート状または布
状補綴材料(通常パツチといわれている)は、用
途に応じて次の3種類に大別される。
By the way, sheet-like or cloth-like prosthetic materials (usually referred to as patches) for use in cardiac surgery are roughly classified into the following three types depending on the purpose.

その第1は心膜補綴材料である。の材料は特に
再手術を必要とする手術の場合に最初の手術で心
膜が傷つく結果、心筋と外部組織とが瘉着するの
を防ぐものであるから、それ自体が柔軟で組織反
応性の無い人工膜が要求される。しかし、心膜補
綴材料には、耐血圧性、耐縫合針・糸性は特に必
要ではなく、この目的に極めて適した材料とし
て、坂本、今井等は既に延伸多孔質PTFEシート
2枚以上をその主延伸方向を交叉させて互いにラ
ミネートした補綴材料について簡単に前記「胸部
外科」誌に発表している。
The first is pericardial prosthetic materials. The material itself is flexible and tissue-reactive because it prevents adhesion between the myocardium and external tissue as a result of damage to the pericardium during the initial surgery, especially in cases of surgery that requires reoperation. No artificial membrane is required. However, pericardial prosthetic materials do not particularly require blood pressure resistance or suture needle/thread resistance, and Sakamoto, Imai, and others have already developed two or more stretched porous PTFE sheets as materials that are extremely suitable for this purpose. A brief article was published in the aforementioned ``Thoracic Surgery'' journal about prosthetic materials laminated to each other with their main stretching directions crossing each other.

第2は心房の欠損部を補修するパツチ材であ
る。中隔欠損補綴材としては、現在PTFEの糸を
製織または編織した布またはメツシユが広く使わ
れている。この種のパツチには両心房間の僅かな
血圧差(5〜10mmHg)がかかるだけであり、両
面が常に血液に接するのでパッチを通しての血流
は問題にならない。そしてその布目あるいは編目
上には、術後次第に組織が形成されるので現在の
パツチ材料で殆んど十分に目的が達成されてい
る。
The second is a patch material that repairs the defective part of the atrium. Currently, cloth or mesh made of woven or knitted PTFE threads is widely used as a prosthetic material for septal defects. This type of patch is subject to only a small blood pressure difference (5-10 mmHg) between the two atria, and blood flow through the patch is not a problem since both sides are in constant contact with blood. Since tissue is gradually formed on the cloth or stitches after surgery, the purpose is almost fully achieved with the current patch materials.

第3は本発明の目的とする補綴材料、即ち心筋
欠損または欠陥部で大きな血圧の加わる部分の補
綴材料である。この材料としては、 A 外面は補綴材料の固定のための適度の組織反
応性があり、しかも内面は組織反応性の無いこ
と、 B 補綴材料内面への血栓の原因となる血小板の
付着のないこと、 C 補綴材料の内方向への組織の生長が可能なこ
と、 D 手術時のプレクロツテイングが不要なこと、 E 血圧により材料が伸びないこと、 F 縫合針・糸により裂けなこと、 G 適度の柔軟性があること、 という要件A〜Gを全て同時に満足する材料であ
ることが望ましい。ここで、要件Aにおける適度
の組織反応性があるとは、次のような意味であ
る。
The third is a prosthetic material that is the object of the present invention, that is, a prosthetic material for areas where large blood pressure is applied due to myocardial defects or defects. This material has the following characteristics: A. The outer surface has appropriate tissue reactivity for fixing the prosthetic material, and the inner surface has no tissue reactivity. B. There is no adhesion of platelets that can cause blood clots to the inner surface of the prosthetic material. , C: Tissues can grow inward from the prosthetic material, D: Pre-cropping during surgery is not required, E: The material does not stretch due to blood pressure, F: Will not be torn by suture needles/threads, G: Moderate It is desirable that the material satisfies all requirements A to G at the same time, such as having the following flexibility. Here, moderate tissue reactivity in requirement A means the following.

一般に体組織が異物に接した場合、その異物の
性質によつて体組織の増殖、体組織の炎症、体組
織の発癌等の種々の反応がひき起こされるが、反
応性が適度であるとは、異物としての補綴材料
が、体組織の炎症、発癌等の好ましくない状態を
ひき起こさず体組織の増殖を高めるように働くも
のであることを意味し、それによつて要件Cであ
る補綴材料の内方向へ組織の生長を可能とするも
のである。上記要件A〜Gを満足する材料は今迄
知られていなかつた(なお、第1の補綴材料に
は、上記D.E.F.の要件に対する配慮は不要であ
り、また第2のパツチ材に対しては、B.D.E.の要
件に対する配慮は殆んど不要である)。
Generally, when body tissues come into contact with a foreign substance, various reactions such as proliferation of the body tissue, inflammation of the body tissue, and carcinogenesis of the body tissue are caused depending on the nature of the foreign substance. , means that the prosthetic material as a foreign substance acts to increase the proliferation of body tissues without causing unfavorable conditions such as inflammation or carcinogenesis of body tissues, and therefore, requirement C of the prosthetic material is satisfied. It allows tissue to grow inward. Until now, no material has been known that satisfies the above requirements A to G (note that consideration of the above DEF requirements is not required for the first prosthetic material, and for the second patch material, (There is little need to consider BDE requirements).

しかし、この第3のタイプの補綴材料は、臨床
的には先天性心疾患のうち、右室流出路狭窄を伴
なう心奇形群、フアロー四徴症、右室2腔症、心
室中隔欠損兼肺動脈狭窄、漏斗部狭窄を合併した
肺動脈狭窄症など右室流出路形成を必要とするす
べての疾患に応用でき、また完全大血管転位症、
一部の両大血管右室起始症でマスタード手術を施
行する際に機能的左房拡大にも応用でき、相当数
必要とされている。
However, this third type of prosthetic material is clinically used for congenital heart diseases such as cardiac malformations with right ventricular outflow tract stenosis, tetralogy of Farot, right ventricular two-chamber disease, and ventricular septum. It can be applied to all diseases that require right ventricular outflow tract formation, such as defective pulmonary artery stenosis, pulmonary artery stenosis complicated by infundibulum stenosis, and complete transposition of the great vessels.
It can also be applied to functional left atrial enlargement when performing Mustard surgery for some cases of bilateral great vessel right ventricular origin, and a considerable number of them are needed.

この見地から、本発明者は、この第3のタイプ
のシート状補綴材料をつくるべく種々の検討をし
た結果、上記要求を同時にすべて満足する補綴材
料である本発明を完成した。
From this point of view, the present inventor conducted various studies to create the third type of sheet-like prosthetic material, and as a result, completed the present invention, which is a prosthetic material that simultaneously satisfies all of the above requirements.

即ち、本発明は体組織と接触する側に位置し、
体組織と適度の反応性を有する製織布または編織
布と、血流と接触する側に位置する延伸多孔質ポ
リテトラフロロエチレン層とからなり、該延伸多
孔質ポリテトラフロロエチレン層が多数の微小結
節が多数のフイブリルによつて互に結合され、微
小結節とフイブリルとの間に連続気孔性の微孔が
形成された微細構造を有する心臓、血管外科用医
療用シート状補綴材料である。
That is, the present invention is located on the side that comes into contact with body tissue,
It consists of a woven or knitted fabric that has appropriate reactivity with body tissues and an expanded porous polytetrafluoroethylene layer located on the side that comes into contact with blood flow, and the expanded porous polytetrafluoroethylene layer has a large number of layers. This is a medical sheet-like prosthetic material for cardiac and vascular surgery having a microstructure in which micronodules are interconnected by a large number of fibrils and continuous micropores are formed between the micronodules and the fibrils.

先ず、本発明において使用される製織布または
編織布としては、従来から医療用材料として市販
されている織地または編地であつて体組織と適度
の反応性を有するものであればいずれも使用可能
であるが、ポリエステルの糸あるいは延伸PTFE
の糸を製織あるいは編織したポリエステル布ある
いはPTFE布が好適である。そしてポリエステル
の糸よりなるポリエステル布としては平織りポリ
エステル布、ポリエステルトリコツト布が好まし
く、特に片面を起毛したポリエステルトリコツト
布が好適である。また延伸PTFEの糸よりなる
PTFEの布としてはポリテトラフロロエチレント
リコツト布が好ましい。
First, the woven or knitted fabric used in the present invention may be any woven or knitted fabric that has been commercially available as a medical material and has appropriate reactivity with body tissue. Possible, but polyester thread or oriented PTFE
A polyester cloth or a PTFE cloth woven or knitted from yarns is suitable. The polyester cloth made of polyester threads is preferably a plain-woven polyester cloth or a polyester tricot cloth, and a polyester tricot cloth with raised one side is particularly suitable. It is also made of stretched PTFE thread.
As the PTFE cloth, polytetrafluoroethylene tricot cloth is preferable.

つぎに延伸多孔質ポリテトラフロロエチレン
(以下、EPTFEという)層は、特公昭48−44664
号公報、特公昭51−18991号公報、特公昭52−
26547号公報などに記載された方法によつて製造
される焼成ないし未焼成の延伸多孔質PTFE膜ま
たはシートであつて、多数の微小結節が多数のフ
イブリル(微細繊維によつて互に結合され、微小
結節とフイブリルとの間に連続気孔性の微孔が形
成された微細構造を有する延伸多孔質PTFE膜ま
たはシートである。
Next, the expanded porous polytetrafluoroethylene (hereinafter referred to as EPTFE) layer is
Publication No. 18991, Special Publication No. 18991, Special Publication No. 18991, Special Publication No. 18991-
A fired or unfired stretched porous PTFE membrane or sheet produced by the method described in Japanese Patent No. 26547, etc., in which a large number of micronodules are bonded to each other by a large number of fibrils (fine fibers), It is a stretched porous PTFE membrane or sheet with a microstructure in which continuous micropores are formed between micronodules and fibrils.

その製造方法を略記すれば次のとおりである。
PTFE微粉末と液状潤滑剤との混和物(混合重量
比約80:20)を予備成形し、この予備成形物を所
望の形状(本発明の場合はシート状)にペースト
押出しし、必要に応じてカレンダー圧延する。こ
の押出し成形品(結晶化度約95%以上)から液状
潤滑剤を適宜の手段で(主に揮発による)除去
し、ついPTFEの融点以下の高められた温度で一
以上の方向に単位時間当り伸張比率が10%/秒以
上で伸長し、必要に応じて伸長した材料を327℃
以上の温度に加熱焼成する。こうして得られるも
のは、マトリツクス引張り強さ514Kg/cm2以上の、
強度の高い前記のような微細構造を有する多孔質
PTEFシートである。この多孔質PTFEシートの
物性は、特公昭51−18991号公報に詳しく述べら
れているとおりである。しかもそれは加工条件
(単位時間当りの延伸比率、延伸比、温度、焼成
条件など)を変えることにより、広範囲に変化さ
せることがきる。この多孔質PTFEシートの物性
の中、本発明のような医療用シート状補綴材料と
しての適性に関与する性質としてはフイブリル
長、空孔率、肉厚を規定するのが便利であり、そ
してフイブリル長は0.1〜1000μm、空孔率50%以
上、肉厚0.01mm〜2mm程度のものが本発明の目的
に対して適当である。なお、前記ような広範囲の
肉厚ものをつくるには、単層シートとしてつくる
ことも可能であるが、シートの方向性、強度、止
血性、抗血栓性などを考えると、これをラミネー
トとしてつくる方が目的に適うものが得やすい。
その際の留意点としてはシートの方向性をなくす
ためには、延伸方向を交叉させるのがよく、抗血
栓性、止血性を良くするには、布地を接着させな
い方の表面に、孔径の小さいシートを配置すると
よい。
The manufacturing method is briefly as follows.
A mixture of PTFE fine powder and liquid lubricant (mixing weight ratio of approximately 80:20) is preformed, and this preform is paste-extruded into a desired shape (in the case of the present invention, a sheet shape), and as needed. Calender rolling. The liquid lubricant is removed from this extruded product (crystallinity of about 95% or more) by appropriate means (mainly by volatilization), and then the liquid lubricant is removed in one or more directions per unit time at an elevated temperature below the melting point of PTFE. Stretch the material at a stretching rate of 10%/sec or higher, and if necessary, heat the stretched material to 327°C.
Heat and bake at a temperature above. The material obtained in this way has a matrix tensile strength of 514 kg/cm 2 or more.
Porous with the above-mentioned microstructure with high strength
It is a PTEF sheet. The physical properties of this porous PTFE sheet are as described in detail in Japanese Patent Publication No. 18991/1983. Moreover, it can be varied over a wide range by changing processing conditions (stretching ratio per unit time, stretching ratio, temperature, firing conditions, etc.). Among the physical properties of this porous PTFE sheet, it is convenient to specify the fibril length, porosity, and wall thickness as properties related to its suitability as a medical sheet prosthetic material such as the present invention. A length of 0.1 to 1000 μm, a porosity of 50% or more, and a wall thickness of about 0.01 mm to 2 mm are suitable for the purpose of the present invention. Although it is possible to make a single-layer sheet to make a wide range of thicknesses as mentioned above, considering the directionality, strength, hemostasis, antithrombotic properties, etc. of the sheet, it is recommended to make it as a laminate. It's easier to get something that suits your purpose.
The points to keep in mind in this case are that to eliminate the directionality of the sheet, it is best to cross the stretching directions, and to improve antithrombotic and hemostatic properties, the surface to which the fabric is not attached should be stretched with small pores. It is a good idea to arrange the sheets.

上記の製織布または編織布とEPTFE層の2種
の材料を互に重ね合せて結合させるには、上記2
種の材料の間に介在させた網状の接着剤、もしく
は点状または粉状に分布させた接着剤により接着
する。
In order to overlay and bond the two materials, the woven or knitted fabric and the EPTFE layer, to each other,
Adhesion is achieved by a network of adhesive interposed between the seed materials, or by an adhesive distributed in dots or powder.

これに使用する適用可能な接着剤としては、熱
溶融性の網状材料例えばポリエチレンのネツト
(商品名:デルネツト)、ポリエステルやナイロン
の不織布のような熱溶融性樹脂、ポリエステルあ
るいはナイロン粉末、架橋形ポリエステル系接着
剤、合成ゴム系接着剤(ウレタンエラストマー、
ブチルゴムなど)、エマルジヨン系接着剤(醋酸
ビニル樹脂、アクリル樹脂などのエマルジヨン)
などが挙げられる。
Applicable adhesives used for this purpose include hot-melt net materials such as polyethylene net (trade name: Delnet), hot-melt resins such as polyester or nylon nonwovens, polyester or nylon powder, cross-linked polyester adhesives, synthetic rubber adhesives (urethane elastomers,
butyl rubber, etc.), emulsion adhesives (emulsion of vinyl acetate resin, acrylic resin, etc.)
Examples include.

なお、上記2種の材料を結合させる接着剤は、
前述のように網目状に介在させるか、もしくは粉
末状または点状に分布させるのが好適である。そ
の理由は、シート状補綴材料の柔軟性、可撓性を
維持するため、および材料全体として連続気孔性
を保ち、微細構造中への体組織の侵入を可能とす
るためである。
In addition, the adhesive for bonding the above two types of materials is:
As mentioned above, it is preferable to distribute it in the form of a network, or in the form of powder or dots. The reason for this is to maintain the softness and flexibility of the sheet-like prosthetic material, and to maintain continuous porosity as a whole of the material to enable penetration of body tissue into the microstructure.

また上記2種の材料を結合させる際には、中間
に挾んだ接着剤が溶融するか、あるいは硬化が促
進される温度をかける必要がある。それには、接
着に使うロール、シートまたは板を加熱するかあ
るいは前記3者の集合体を金属ドラム上にシワの
無いように固定して、前記温度に保たれた恒温槽
に入れることによつて行なう。なお製織または編
織層がPTFE樹脂である場合は接着剤である樹脂
の溶融を行なう温度を327℃以上にしPTFEの焼
成も同時に行なうことも可能である。
Furthermore, when bonding the above two types of materials, it is necessary to apply a temperature that melts the adhesive sandwiched in between or accelerates curing. This can be done by heating the roll, sheet or plate used for gluing, or by fixing the assembly of the three above on a metal drum without wrinkles and placing it in a constant temperature bath maintained at the above temperature. Let's do it. In addition, when the woven or knitted layer is made of PTFE resin, it is also possible to melt the adhesive resin at a temperature of 327° C. or higher and to simultaneously bake the PTFE.

こうして得られる本発明の医療用シート状補綴
材料を更に補修する患部の曲面に合うように付形
することもできる。そのためには、所望の形状の
金型を用意し、それに前記3者の集合体またはラ
ミネート体を挾んで金型を加熱し、冷却すること
によつて行なえばよい。またこの加熱は樹脂また
は接着剤を溶融させるラミネート工程あるいは、
焼成工程を兼ねたものとしても実施し得る。
The medical sheet-like prosthetic material of the present invention thus obtained can be further shaped to fit the curved surface of the affected area to be repaired. This can be accomplished by preparing a mold of the desired shape, sandwiching the assembly or laminate of the three materials therein, heating the mold, and cooling the mold. This heating is also used in the lamination process to melt the resin or adhesive, or
It can also be carried out as a firing process.

なおまた、本発明の医療用シート状補綴材料は
通常上述のように製織布または編織布とEPTFE
層の2層構造であるが、場合によつては、
EPTFEの2層の間に製織布または編織布を挾む
3層構造とすることもできる。
Furthermore, the medical sheet-like prosthetic material of the present invention is usually made of woven or knitted fabric and EPTFE as described above.
Although it has a two-layer structure, in some cases,
It is also possible to have a three-layer structure in which a woven or knitted fabric is sandwiched between two layers of EPTFE.

このようにして得られた本発明の医療用シート
状補綴材料は、その製織布または編織布の側を体
組織に、そしてEPTFE層を血流に接触するよう
にして適用される。こうすることにより、PTFE
よりも組織反応性の高い布材料は、結合組織によ
り強固に体組織に固定される。このことは、従来
の人工血管の材料としての経験から臨床的にも証
明されている。一方、EPTFE自体は、上記した
B、C、D、G、の条件を満足する良材料である
が、伸展性、縫合針・糸による断裂などに問題が
あり、また組織反応性が低過ぎるために体組織に
よる固定が不充分であつたが、本発明では
EPTFE層の体組織に接触する側(外面)に体組
織と適度の反応性を有する製織布または編織布を
結合させたことによりEPTFEの上記の弱点を補
い、かつその優れた抗血栓性を持つEPTFE面を
血流に接触する面として利用できるようにしたの
で、本発明の医療用シート状補綴材料は上記した
A〜Gのすべての条件を同時に満足した非常に特
色のあるものである。
The medical sheet-like prosthetic material of the present invention thus obtained is applied with the woven or knitted fabric side in contact with body tissue and the EPTFE layer in contact with blood flow. By doing this, PTFE
Fabric materials that are more tissue-reactive than the conventional fabric are more firmly anchored to body tissue by connective tissue. This has been clinically proven through experience as a material for conventional artificial blood vessels. On the other hand, EPTFE itself is a good material that satisfies the above-mentioned conditions B, C, D, and G, but it has problems such as extensibility and tearing due to suture needles and threads, and its tissue reactivity is too low. However, in the present invention, fixation by body tissue was insufficient.
The above-mentioned weaknesses of EPTFE are compensated for by bonding the EPTFE layer with a woven or knitted fabric that is moderately reactive with body tissues on the side (outer surface) that contacts body tissues, and its excellent antithrombotic properties are Since the EPTFE surface can be used as a surface that comes into contact with blood flow, the medical sheet-like prosthetic material of the present invention is very unique in that it simultaneously satisfies all of the conditions A to G above.

本発明の医療用シート状補綴材料の使用方法と
効果の具体例を示すと次の如くである。右室流出
路狭窄に対して主肺動脈から右室流出路に達する
縦切開を施行し、実施例1で製造したシート状補
綴材料を殺菌し手術部位の寸法形状に合わせて切
り取り、EPTFEを内面に向けて3−0または5
−0程度のモノフイラメントナイロン糸、または
他のモノフイラメント糸の連続縫合で縫着する。
Specific examples of the usage and effects of the medical sheet-like prosthetic material of the present invention are as follows. For right ventricular outflow tract stenosis, a vertical incision was made from the main pulmonary artery to the right ventricular outflow tract, and the sheet-shaped prosthetic material manufactured in Example 1 was sterilized and cut to fit the size and shape of the surgical site, and EPTFE was applied to the inner surface. towards 3-0 or 5
Sewn with a continuous stitch of -0 grade monofilament nylon thread or other monofilament thread.

マスタード手術に対する機能的左房拡大の目的
では、右房を右肺静脈流入部附近の左房まで横切
開し、卵円形に切取つた実施例1で製造したシー
ト状補綴材料を同様に連続縫合で縫着する。本材
料は適度の柔軟性をもつため心切開創に密着し、
縫合線からの出血も軽微で止血しやすく、また内
面の抗血栓性が高いために塞栓症の発現をみてい
ない。
For the purpose of functional left atrium expansion for Mustard surgery, the right atrium was transversely incised to the left atrium near the right pulmonary vein inflow, and the sheet-shaped prosthetic material manufactured in Example 1, cut into an oval shape, was similarly sutured continuously. sew. This material has appropriate flexibility, so it adheres closely to the cardiac incision wound,
Bleeding from the suture line is slight and easy to stop, and because the inner surface has high antithrombotic properties, no embolism has occurred.

フアロー四微症で右心室の流出路が低形成の強
い症例では、右室流出路から主肺動脈にいたる縦
切開をパツチにて拡大する必要があり、この場合
比較的高圧にたえる構造でしかも抗血栓性のある
材料が望ましい。そこで実施例1で製造したシー
ト状補綴材料を3×5〜7cm程度の長楕円形に切
りとり、3−0又は4−0のモノフイラメントナ
イロン糸で連続縫合し、流出路の拡大を施行し
た。この際、適度の柔軟性をもつた本材料は、流
出路の形状に合わせて成形するのが容易で、しか
も術後の出血が少なく好適であつた。また長期遠
隔成績でも血栓、塞栓などの合併症もなく、偽性
動脈瘤形成もみられていない。
In patients with Fallot's tetralogy where the right ventricular outflow tract is severely hypoplastic, it is necessary to enlarge the vertical incision from the right ventricular outflow tract to the main pulmonary artery with a patch. Materials with antithrombotic properties are preferred. Therefore, the sheet-like prosthetic material produced in Example 1 was cut into a long oval shape of approximately 3 x 5 to 7 cm, and the outflow channel was enlarged by continuous stitching with 3-0 or 4-0 monofilament nylon thread. In this case, the present material, which had appropriate flexibility, was suitable because it was easy to mold to match the shape of the outflow tract, and there was little post-operative bleeding. In addition, long-term long-term results showed no complications such as thrombosis or embolism, and no pseudoaneurysm formation.

また、完全大血管転位症の機能的左房拡大の場
合に、実施例2で製造したシート状補綴材料をガ
ス滅菌し、楕円形(長径5cm、短径4cm)に切り
取り、3−0又は4−0のモノフイラメントナイ
ロン糸で連続縫合にて縫着した。本材料は適度の
強度と柔軟性が有り、縫合し易く、パツチ面から
の出血もなく、心臓面に良く順応した。
In addition, in the case of functional left atrial enlargement due to complete transposition of the great arteries, the sheet-like prosthetic material produced in Example 2 was gas sterilized, cut into an oval shape (major axis 5 cm, minor axis 4 cm), and 3-0 or 4 cm. -0 monofilament nylon thread by continuous suture. This material had appropriate strength and flexibility, was easy to suture, did not bleed from the patch surface, and conformed well to the cardiac surface.

このように本発明の医療用シート状補綴材料を
用いた手術ではいずれも良好な成績をおさめてい
る。そして術後期間において右室流出路の偽性心
室瘤形成もなく、また心房での拡大術用に使用し
たものも含めて、血栓、塞血栓の発生をみていな
い。特に術中の出血が減少したことは特記すべき
点で、このため手術時間が短縮され、血行動態の
安定がみられた。
As described above, good results have been achieved in all surgeries using the medical sheet-like prosthetic material of the present invention. During the postoperative period, there was no formation of pseudoventricular aneurysm in the right ventricular outflow tract, and no thrombi or embolism occurred, including those used for dilatation of the atrium. Of particular note is the reduction in intraoperative bleeding, which shortened the surgical time and stabilized hemodynamics.

実施例 1 特公昭48−44664号の方法に従つて、ポリテト
ラフロロエチレン微粉末(商品名:テフロン6J)
とその重量の約18%のナフサとの混和物を予備成
形し、その予備成形品をラム押出機によつて約
0.7mm厚のシート状に押出す。このシート状物を
カレンダーロールによつて厚さ約0.03mmに圧延
し、該圧延シートを約300℃に加熱してナフサを
除去すると同時に長さ方向に約5倍延伸して未焼
成延伸PTFEシートを得た。この未焼成延伸
PTFEシートの物性は下記の通りであつた。
Example 1 Polytetrafluoroethylene fine powder (trade name: Teflon 6J) was prepared according to the method of Japanese Patent Publication No. 48-44664.
and about 18% of its weight of naphtha, and the preform is processed by a ram extruder to
Extrude into a 0.7mm thick sheet. This sheet-like material is rolled to a thickness of about 0.03 mm using calender rolls, and the rolled sheet is heated to about 300°C to remove naphtha, and at the same time stretched about 5 times in the length direction to form an unfired stretched PTFE sheet. I got it. This unfired stretching
The physical properties of the PTFE sheet were as follows.

肉厚 :0.03mm 空隙率:約80% 平均孔径:0.4μm 密度 :0.4g/c.c. 上記未焼成PTFEシート4枚(60×30cm、長さ
×巾)−これらシートのフイブリル配向は、縦お
よび横の2種類、各2枚−を交互に金属製の筒
(直径15cm、長さ30cm)の曲面上にシワの無いよ
うにして順次重ね合せ、その長手方向の対向する
両端をステンレス片とクランプを用いて金属円筒
面に固定した。次に、前記金属筒を370℃に保つ
た恒温槽中に30分間入れた後、取り出し、空冷し
て焼成延伸PTFE四層ラミネートを得た。
Wall thickness: 0.03mm Porosity: Approximately 80% Average pore size: 0.4μm Density: 0.4g/cc The above four unfired PTFE sheets (60 x 30cm, length x width) - The fibril orientation of these sheets is vertical and horizontal. Two types of each, two of each type, were stacked one after another on the curved surface of a metal cylinder (diameter 15 cm, length 30 cm) without wrinkles, and the opposing longitudinal ends were secured with stainless steel pieces and clamps. was used to fix it on a metal cylindrical surface. Next, the metal tube was placed in a constant temperature bath maintained at 370° C. for 30 minutes, then taken out and cooled in air to obtain a fired expanded PTFE four-layer laminate.

次に、平らな板上に市販の医用の平織ポリエス
テル布(密度:経糸75D、38.5本/cm、緯糸70D、
33.5本/cm)を平らに広げ、その上にポリエチレ
ンネツト(商品名:デルネツト)、次に上記した
焼成延伸PTFEラミネートを夫々シワのないよう
に重ね、その上から加熱した家庭用600Wのアイ
ロンをかけた。このアイロンがけにより前記ポリ
エチレンネツトは溶融し、その両面に接する前記
ポリエステル布の織り目および上記PTFEラミネ
ートの微細孔中に圧入されて固化し、こうしてポ
リエステル布とPTFEラミネートが一体化された
医療用シート状補綴材料が得られた。
Next, a commercially available medical plain-woven polyester cloth (density: warp 75D, 38.5 threads/cm, weft 70D,
33.5 pcs/cm) was spread flat, and then polyethylene net (product name: Delnet) was layered on top of it, followed by the above-mentioned fired and stretched PTFE laminate so that there were no wrinkles. I put it on. By this ironing, the polyethylene net is melted and press-fitted into the weave of the polyester cloth and the micropores of the PTFE laminate that are in contact with both sides of the net, and solidified, thus forming a medical sheet in which the polyester cloth and the PTFE laminate are integrated. A prosthetic material was obtained.

この医療用シート状補綴材料の強度をインスト
ロン型引張り試験機で引速200mm/分で測定した
結果を下に示す。
The strength of this medical sheet prosthetic material was measured using an Instron tensile tester at a pulling speed of 200 mm/min, and the results are shown below.

引張り強さ(縦方向)12.6Kg/cm最大張力発生
時の伸び率52% 引張り強さ(横方向)8.6Kg/cm最大張力発生
時の伸び率48% また外科用縫合糸による材料の引裂きに対する
抵抗力を、上記と同じ引張試験機で測定した。そ
の場合、一方の引張りクランプには、補綴材料試
験片を貫通させた4−0縫合糸の両端を取り付
け、他方のクランプには試験片をそのまま取りつ
け、200mm/分の引速で試験を行ない下記の結果
を得た。
Tensile strength (longitudinal direction) 12.6 Kg/cm Elongation rate at maximum tension of 52% Tensile strength (lateral direction) 8.6 Kg/cm Elongation rate at maximum tension of 48% Also resistant to tearing of the material by surgical sutures Resistance was measured with the same tensile testing machine as above. In that case, one tension clamp is attached with both ends of a 4-0 suture passed through the prosthetic material specimen, the other clamp is attached with the specimen intact, and the test is performed at a pulling speed of 200 mm/min. I got the result.

縫合糸が2.6Kgで破断、そのとき針穴の広がり
は、4mm 縫合糸が2.3Kgで破断、そのとき針穴の広がり
は、7mm 実施例 2 市販の片面を起毛した医療用ポリエステル編地
(寸法:20×20cm、重さ:1.85×10-2g/cm2)を、
曲率半径30cmのステンレス製の曲面板の表面上に
起毛面を下にして添わせ、その上に同寸法のポリ
エチレンネツト(商品名:デルネツト)を重ね、
更にその上に実施例1において使用したと同様の
焼成延伸PTFEラミネートを重ね、これらの四辺
を布地が収縮しないようにピンで固定した。次
に、前記ラミネートの上をアルミ箔で覆い、更に
ステンレス織布で押え、該曲面板を恒温槽中で
150℃で30分間加熱し、室温に放冷して目的とす
る医療用シート状補綴材料を得た。
The suture thread breaks at 2.6 kg, and the needle hole spreads out to 4 mm. The suture thread breaks at 2.3 kg, and the needle hole spreads to 7 mm. : 20×20cm, weight: 1.85×10 -2 g/cm 2 ),
Place the brushed side down on the surface of a stainless steel curved plate with a radius of curvature of 30 cm, and layer polyethylene net (product name: Delnet) of the same size on top of it.
Furthermore, a fired stretched PTFE laminate similar to that used in Example 1 was placed on top of this, and these four sides were fixed with pins to prevent the fabric from shrinking. Next, cover the laminate with aluminum foil, press it with stainless steel fabric, and place the curved plate in a constant temperature bath.
The mixture was heated at 150°C for 30 minutes and allowed to cool to room temperature to obtain the desired medical sheet prosthetic material.

この補綴材料の強度を実施例1と同様にして測
定した結果を次に示す。
The strength of this prosthetic material was measured in the same manner as in Example 1, and the results are shown below.

引張り強さ(縦方向)13.2Kg/cmの最大張力発
生時の伸び率52% 引張り強さ(横方向)8.4Kg/cm最大張力発生
時の伸び率108% 縫合糸による引裂き試験 2.0Kgの張力がかかつているときの針穴の広が
りは4.5mm(縦) 2.2Kgの張力で縫合糸が破断し、そのときの針
穴の広がりは9mm(横)
Tensile strength (longitudinal direction) 52% elongation at maximum tension of 13.2Kg/cm Tensile strength (transverse direction) 8.4Kg/cm Elongation 108% at maximum tension Tear test with suture Tear at 2.0Kg When tension is applied, the needle hole spreads 4.5 mm (vertical).When the suture thread breaks with a tension of 2.2 kg, the needle hole spreads 9 mm (horizontal).

Claims (1)

【特許請求の範囲】 1 体組織と接触する側に位置し、体組織と適度
の反応性を有する製織布または編織布と、血流と
接触する側に位置する延伸多孔質ポリテトラフロ
ロエチレン層とからなり、該延伸多孔質ポリテト
ラフロロエチレン層が多数の微小結節が多数のフ
イブリルによつて互に結合され、微小結節とフイ
ブリルとの間に連続気孔性の微孔が形成された微
細構造を有する心蔵、血管外科用医療用シート状
補綴材料。 2 延伸多孔質ポリテトラフロロエチレン層が一
枚の延伸多孔質ポリテトラフロロエチレンシート
である特許請求の範囲第1項記載の心臓、血管外
科用医療用シート状補綴材料。 3 延伸多孔質ポリテトラフロロエチレン層が2
枚以上の延伸多孔質ポリテトラフロロエチレンシ
ートの積層物である特許請求項範囲第1項記載の
心臓、血管外科用医療用シート状補綴材料。 4 製織布または編織布と延伸多孔質ポリテトラ
フロロエチレン層とが網状の接着剤、もしくは点
状または粉状に分布された接着剤により接着され
ている特許請求の範囲第1項ないし第3項のいず
れかに記載の心臓、血管外科用医療用シート状補
綴材料。 5 手術部位の形状に合わせて曲面に加工された
特許請求の範囲第1項ないし第4項のいずれかに
記載の心臓、血管外科用医療用シート状補綴材
料。
[Scope of Claims] 1. A woven or knitted fabric that is located on the side that comes into contact with body tissue and has appropriate reactivity with the body tissue, and an expanded porous polytetrafluoroethylene that is located on the side that comes into contact with the bloodstream. The stretched porous polytetrafluoroethylene layer has a large number of micro nodules interconnected by a large number of fibrils, and continuous micropores are formed between the micro nodules and the fibrils. Medical sheet prosthetic material for vascular surgery with a structure. 2. The medical sheet-shaped prosthetic material for cardiac and vascular surgery according to claim 1, wherein the expanded porous polytetrafluoroethylene layer is a single expanded porous polytetrafluoroethylene sheet. 3 Two stretched porous polytetrafluoroethylene layers
The medical sheet-shaped prosthetic material for cardiac and vascular surgery according to claim 1, which is a laminate of two or more stretched porous polytetrafluoroethylene sheets. 4. Claims 1 to 3, in which the woven or knitted fabric and the stretched porous polytetrafluoroethylene layer are bonded by a network adhesive, or an adhesive distributed in dots or powders. The sheet-shaped prosthetic material for medical use in cardiac and vascular surgery according to any one of paragraphs. 5. The medical sheet-shaped prosthetic material for cardiac and vascular surgery according to any one of claims 1 to 4, which is processed into a curved surface to match the shape of the surgical site.
JP8640979A 1979-07-10 1979-07-10 Sheettshaped prosthetic material for medical treatment Granted JPS5611062A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP8640979A JPS5611062A (en) 1979-07-10 1979-07-10 Sheettshaped prosthetic material for medical treatment

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP8640979A JPS5611062A (en) 1979-07-10 1979-07-10 Sheettshaped prosthetic material for medical treatment

Publications (2)

Publication Number Publication Date
JPS5611062A JPS5611062A (en) 1981-02-04
JPS645904B2 true JPS645904B2 (en) 1989-02-01

Family

ID=13886059

Family Applications (1)

Application Number Title Priority Date Filing Date
JP8640979A Granted JPS5611062A (en) 1979-07-10 1979-07-10 Sheettshaped prosthetic material for medical treatment

Country Status (1)

Country Link
JP (1) JPS5611062A (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4340091A (en) * 1975-05-07 1982-07-20 Albany International Corp. Elastomeric sheet materials for heart valve and other prosthetic implants
JPS59174161A (en) * 1983-03-23 1984-10-02 呉羽化学工業株式会社 Body compatible plastic composite material
US5527353A (en) * 1993-12-02 1996-06-18 Meadox Medicals, Inc. Implantable tubular prosthesis
US20120071846A1 (en) * 2010-09-22 2012-03-22 American Surgical Sponges, Llc Medical Tool Deflection and Resistant Surgical Sponge
CN101953721B (en) * 2010-10-28 2013-06-05 东华大学 Preparation method of multilayer composite artificial vascular membrane with shape memory function

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS515897A (en) * 1974-07-02 1976-01-19 Hiroshi Matsumoto Jinkoketsukan oyobi sonoseizohoho

Also Published As

Publication number Publication date
JPS5611062A (en) 1981-02-04

Similar Documents

Publication Publication Date Title
US5700287A (en) Prosthetic vascular graft with deflectably secured fibers
US5910168A (en) Prosthetic vascular graft
JP2939337B2 (en) Three-dimensional braided soft tissue prosthesis
EP1794248B1 (en) Elastomeric radiopaque adhesive composite and prosthesis
EP2819716B1 (en) Improved biocompatible surfaces and devices incorporating such surfaces
CA2554631C (en) Pressure lamination method for forming composite eptfe/textile and eptfe/stent/textile prostheses
US5197976A (en) Manually separable multi-lumen vascular graft
JP2006524117A (en) Arteriovenous grafts with the ability to seal themselves quickly after surgery
JPH10258073A (en) Implantable tubular artificial organ for soft tissue
WO2000043052A1 (en) Vascular graft with improved surface flow
JP2006511282A (en) Multi-lumen vascular graft with improved self-sealing properties
CN112043875B (en) Intravascular stent covering membrane for in-situ intimal regeneration and preparation method thereof
US4596577A (en) Napped fluororesin materials having continuous pores, and a method of manufacturing the same
JPS645904B2 (en)
EP0057590A2 (en) Napped fluororesin material having continuous pores, and a method of manufacturing the same
EP1016384B1 (en) Blood vessel prosthesis
JP3591868B2 (en) Artificial prosthesis
US20240156583A1 (en) Flexible composite laminate with high suture retention strength and method of making same
JPH1199163A (en) Blood vessel prosthetic material
Hardy et al. An acrylate-amide foam arterial prosthesis
Mankodi Application of textile materials in cardiovascular implants
JPH0459899B2 (en)
JPS61103448A (en) Medical sheet like prosthetic material having x-ray contrast property
AU2015258286A1 (en) Improved biocompatible surfaces and devices incorporating such surfaces